195 Followers on Owler
OverviewCompetitorsAcquisitionsInvestmentsNews & Insights

Servier Laboratories Investments

Servier Laboratories has invested in 3 companies and its latest investment was OSE Immunotherapeutics on Dec 27, 2016

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

OSE Immunotherapeutics is a France-based biotechnology company that researches and develops immunotherapies for the treatment of cancer and autoimmune diseases.
$10.7M
Dec 27, 2016
-
GeNeuro is a Switzerland-based biopharmaceutical company that researches and develops antibody therapies for the treatment of autoimmune and neurodegenerative diseases.
-
Dec 17, 2015
-
MacroGenics discovers, develops, and delivers biologic for the treatment of cancer, autoimmune disorders, and infectious diseases.
$10M
Aug 21, 2013
-

Frequently Asked Questions about Servier Laboratories

  1. What is Servier Laboratories investing in?

    Servier Laboratories has invested in 3 companies including OSE Immunotherapeutics, GeNeuro and MacroGenics

  2. What company did Servier Laboratories invest in?

    Servier Laboratories invested in a total 3 companies including OSE Immunotherapeutics, GeNeuro and MacroGenics

  1. What are the top 3 investments by Servier Laboratories?

    The top companies in which Servier Laboratories invested are OSE Immunotherapeutics, GeNeuro and MacroGenics